IVVD
Invivyd, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.76
+1.22%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.11
- Revenue estimate
- $15.1M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.11
- Revenue actual
- $14.3M
- Revenue estimate
- $14.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -48.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $10 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.11 | -$0.14 | Miss -31.25% | $14.3M |
| May 14, 2026 | -$0.08 | -$0.13 | Miss -62.50% | $13.7M |
| Mar 5, 2026 | -$0.08 | -$0.15 | Miss -80.07% | $17.2M |
| Nov 6, 2025 | -$0.05 | -$0.06 | Miss -20.00% | $13.1M |
| Aug 14, 2025 | -$0.04 | -$0.12 | Miss -200.00% | $11.8M |
| May 15, 2025 | -$0.04 | -$0.14 | Miss -250.00% | $11.3M |
| Mar 20, 2025 | -$0.25 | -$0.15 | Beat 40.00% | $13.8M |
| Nov 14, 2024 | -$0.33 | -$0.51 | Miss -54.55% | $9.3M |
| Aug 14, 2024 | -$0.37 | -$0.40 | Miss -8.11% | $2.3M |
| May 9, 2024 | -$0.51 | -$0.38 | Beat 25.49% | — |
| Nov 9, 2023 | -$0.54 | -$0.36 | Beat 33.33% | — |
| Aug 10, 2023 | -$0.40 | -$0.46 | Miss -15.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026